Recently, Shanghai Easy-Flow Medical Tech Co., Ltd. ("Easy-Flow^™") is pleased to announce that its independently developed EF-Salween^® 

Mechanical Thrombectomy System has been officially included in the "Pudong New Area Biomedical Industry High-Quality Development 

Program 2025" by the Pudong New Area Science Technology and Economic Commission.

As a medical device company based in Pudong New Area, Easy-Flow^™ has been focusing on peripheral vascular intervention, committed to 

developing comprehensive, reliable and minimally invasive solutions for vascular diseases, while continuously promoting the clinical translation 

of technologies and products.

The inclusion recognizes Easy-Flow^™'s technological innovation capabilities and the clinical value of its products. The EF-Salween^® Mechanical 

Thrombectomy System adopts unique thrombus removal technology to efficiently clear vascular thrombi. Moving forward, Easy-Flow^™ will 

continue to increase R&D investment, deepen industry-academia-research collaboration, and advance the development and clinical application 

of more innovative products. This achievement will further strengthen Easy-Flow™'s technological advantages in peripheral vascular intervention 

while accelerating its global expansion to benefit more patients worldwide.